Singapore's Industry-Academic Partnerships Augment Oligonucleotide Therapeutics Innovations

Dr. Peiqing Zhang, Scientific Director, Cytiva (Left) Dr. Timothy Tan, Associate Professor and Leading Investigator, NT...

January 16, 2026 | Friday | Opinion
Taiwan-U.S. innovation ties deepen to bolster AI, semiconductors, and health technology startups

To accelerate the co-development of Taiwan–U.S. startup ecosystems in artificial intelligence (AI), semiconductors...

January 16, 2026 | Friday | News
AdCella and Shanghai Cell Therapy Group launch global collaboration on groundbreaking cancer therapy

Australia-based AdAlta Limited, developer of next generation cell and protein therapeutic products, and its cellular imm...

January 15, 2026 | Thursday | News
Taiwan's Leadgene Biosolutions expands product portfolio for metabolic research

Taiwan-based startup Leadgene Biosolutions has announced the expansion of its product portfolio following its strategic ...

January 14, 2026 | Wednesday | News
Curi Bio launches Asia-Pacific hub following full acquisition of Quvit Bio in South Korea

US-based Curi Bio, the leader in delivering human-relevant functional data for drug discovery and development, has annou...

January 13, 2026 | Tuesday | News
Taiwan's OBI Pharma inks agreement US-based TegMine Therapeutics for glycan-targeting ADC

Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San Francisco...

January 13, 2026 | Tuesday | News
China's MediLink signs additional exclusive licensing deal with Roche for $570 M

China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for ...

January 12, 2026 | Monday | News
Revvity collaborates with Eli Lilly to expand access to AI drug discovery models

US-based Revvity, Inc. has announced a collaboration with Eli Lilly and Company (Lilly) that expands acce...

January 12, 2026 | Monday | News
Australia's Avance Clinical strengthens global oncology offering with acquisition of LumaBridge

Avance Clinical, a full-service Australia headquartered contract research organisation (CRO) focused on accelerating cli...

January 7, 2026 | Wednesday | News
Ribo Life Science successfully lists on Main Board of Hong Kong Stock Exchange

Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...

January 9, 2026 | Friday | News
Xellar, Woojung Bio to advance AI-enabled organ-on-a-chip preclinical models

US-based startup Xellar Biosystems, a globally leading innovator in next-generation artificial intelligence (AI)- a...

January 8, 2026 | Thursday | News
Pandorum Technologies and Nucelion Therapeutics focus on treating ocular diseases in APAC region

Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmab...

January 6, 2026 | Tuesday | News
Insilico Medicine announces $888 M multi-year collaboration with Servier for drug discovery in oncology

Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...

January 5, 2026 | Monday | News
Insilico Medicine lists on Hong Kong Stock Exchange, showing largest Hong Kong biotech IPO

Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence ...

January 2, 2026 | Friday | News
Momentum in Motion: What Will Shape APAC’s Life Sciences Landscape in 2026?

Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...

January 3, 2026 | Saturday | Opinion
Japan Pushes Startups to Power the Next Biotech Cycle

The Japanese government has stepped up efforts to strengthen its startup ecosystem, rolling out a series of initiatives ...

January 3, 2026 | Saturday | Analysis
Reshaping Asia’s Healthcare with mRNA Innovation

The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the bio...

January 3, 2026 | Saturday | Opinion
The Future of mRNA Is Being Built in APAC

mRNA first entered the global spotlight during COVID-19, turning companies such as Moderna and BioNTech into household n...

January 3, 2026 | Saturday | Analysis

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls